Icon

FAVLYXA - (250MG/10ML (25MG/ML); SOLUTION)

FLUOROURACIL None
250MG/10ML (25MG/ML); SOLUTION
Less Than $1000 mn
None None
None None
None None
FAVLYXA is a nucleoside metabolic inhibitor indicated for the treatment of patients with: •Adenocarcinoma of the Colon and Rectum •Adenocarcinoma of the Breast •Gastric Adenocarcinoma •Pancreatic Adenocarcinoma
Yes

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.